Open Access Green as soon as Postprint is submitted to ZB.
Dairy intake and Parkinson's disease: A mendelian randomization study.
Mov. Disord. 37, 857-864 (2022)
BACKGROUND: Previous prospective studies highlighted dairy intake as a risk factor for Parkinson's disease (PD), particularly in men. It is unclear whether this association is causal or explained by reverse causation or confounding. OBJECTIVE: The aim is to examine the association between genetically predicted dairy intake and PD using two-sample Mendelian randomization (MR). METHODS: We genotyped a well-established instrumental variable for dairy intake located in the lactase gene (rs4988235) within the Courage-PD consortium (23 studies; 9823 patients and 8376 controls of European ancestry). RESULTS: Based on a dominant model, there was an association between genetic predisposition toward higher dairy intake and PD (odds ratio [OR] per one serving per day = 1.70, 95% confidence interval = 1.12-2.60, P = 0.013) that was restricted to men (OR = 2.50 [1.37-4.56], P = 0.003; P-difference with women = 0.029). CONCLUSIONS: Using MR, our findings provide further support for a causal relationship between dairy intake and higher PD risk, not biased by confounding or reverse causation. Further studies are needed to elucidate the underlying mechanisms. © 2022 International Parkinson and Movement Disorder Society.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Dairy Intake; Parkinson's Disease; Mendelian Randomization; Ischemic-heart-disease; Milk Consumption; Risk; Metaanalysis; Association; Genotype
ISSN (print) / ISBN
0885-3185
e-ISSN
1531-8257
Journal
Movement Disorders
Quellenangaben
Volume: 37,
Issue: 4,
Pages: 857-864
Publisher
Wiley
Publishing Place
111 River St, Hoboken 07030-5774, Nj Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Human Genetics (IHG)
Grants
National Research Foundation of South Africa (NRF)
Universiteit Stellenbosch
Medical Research Council
Ministerio de Ciencia e Innovación
Michael J Fox Foundation
Karolinska Institutet
Italian Ministry of Health
German Research Council
EU Joint Program for Neurodegenerative Disease research
Eesti Teadusagentuur
MSA Coalition
Multiple Sclerosis Society of Western Australia
Université Paris-Saclay
UK Medical Research Council
Swedish Research Council
South African Medical Research Council
Parkinson's UK
NIH HHS
Consortium canadien en neurodégénérescence associée au vieillissement
Universiteit Stellenbosch
Medical Research Council
Ministerio de Ciencia e Innovación
Michael J Fox Foundation
Karolinska Institutet
Italian Ministry of Health
German Research Council
EU Joint Program for Neurodegenerative Disease research
Eesti Teadusagentuur
MSA Coalition
Multiple Sclerosis Society of Western Australia
Université Paris-Saclay
UK Medical Research Council
Swedish Research Council
South African Medical Research Council
Parkinson's UK
NIH HHS
Consortium canadien en neurodégénérescence associée au vieillissement